CIK 0001821586 · Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 41 41 510 8022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- 4 Conversion Chief Executive Officer acquired 3,167,554 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 2,569,458 shares (conversion)
- 4 Open-market buy 10% owner bought 800,000 shares at $50.00 ($40,000,000)
- 4 Open-market buy 10% owner bought 450,000 shares at an average $45.63 ($20,535,012)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Financial Officer acquired 557,931 shares (conversion)
- 4 Conversion Chief Scientific Officer acquired 598,096 shares (conversion)
- 4 Open-market buy 10% owner bought 827,100 shares at an average $20.28 ($16,774,846)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 4 of 5 · 97 filings